Skip to main content
. 2008 Jun 9;112(8):3517–3525. doi: 10.1182/blood-2008-03-145391

Table 7.

Evaluation of risk

Patient no.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
1 ND ND
2 ND +
3 ND ND ND
4 ND + ND +
5 ND ND + ND ND
6 ND + + ND
7 ND ND ND ND ND
8 ND ND ND
9 +
11 ND + ND ND ND
12 ND ND + ND ND ND + ND ND ND
13 ND ND
14 ND ND ND ND ND ND
15 ND
16 + + ND ND +
17 + ND ND
18 ND ND ND ND + ND ND ND ND ND
19 + ND ND ND +
21 ND ND ND ND ND ND ND ND ND
22 ND ND ND ND + ND ND ND ND ND ND ND +
23 +
Risk, % 6 6 17 0 5 11 12 0 0 0 6 13 0 11 8 9 0 17

+ indicates risk as defined by the theoretical depletion of a Vβ family not expanded in the patient posttransplantation but expanded in the MLC; −, no risk, as defined by (1) no depletion of a Vβ family not expanded in MLC or (2) the depletion of a Vβ family expanded in the patient posttransplantation and the MLC; and ND, not determined.